Fate Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. 

CEO
J. Scott Wolchko
CEOJ. Scott Wolchko
Employees
449
Employees449
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
449
Employees449

FATE Key Statistics

Market cap
2.20B
Market cap2.20B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.19M
Average volume1.19M
High today
$23.14
High today$23.14
Low today
$22.04
Low today$22.04
Open price
$22.80
Open price$22.80
Volume
1.02M
Volume1.02M
52 Week high
$66.56
52 Week high$66.56
52 Week low
$17.10
52 Week low$17.10

Analyst ratings

79%

of 19 ratings
Buy
78.9%
Hold
21.1%
Sell
0%

FATE Earnings

-$0.82
-$0.55
-$0.27
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.